We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Pharmacovigilance – Products

A box of orviglance.
Product News

Ascelia Pharma Successfully Meets Primary Endpoint With Strong Headline Results in Orviglance Phase 3 Study

Ascelia Pharma AB (publ) (ticker: ACE), announced that liver imaging drug candidate, Orviglance®, significantly improved visualization of focal liver lesions, successfully meeting the primary endpoint in the pivotal Phase 3 study SPARKLE.
Antibodies.
Product News

Gyros Protein Technologies Introduces Gyrolab Generic Rodent ADA Kit Reagents To Support Preclinical Immunogenicity Assessment

Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in rodent samples.
Total solution for antibody drug development, Antibody development tools, Functional verification tools, Antibody optimization tools, Quality control tools, Services
Product
Advertisement

Advance Antibody Drug Innovation and Development with Innovative Solutions

To drive the advancement of your antibody drug innovation and development, we offer comprehensive solutions including: target proteins, Fc receptor proteins, kits, beads and services, etc.
A hand holding up a test tube with a model of DNA in the background.
Product News

Top Pharmaceutical Company Evaluates Optimer for Precision Liver Medicine

Optimer delivery vehicle has been shipped to a pharma partner for external evaluation. The specific delivery vehicle could generate new precision therapies for liver disease.
FDA compliant tissue microarray.
Product News

Regulatory Compliant Tissue Microarrays

AMSBIO reports that its extensive range of FDA tissue microarrays reliably enhances tissue cross-reactivity (TCR) and other target validation studies.
Antibodies.
Product News

Therapeutic Potential of CD20 X CD3 Bispecific Antibodies

As of March 2024, the FDA has approved three CD20 × CD3 BsAbs: mosunetuzumab (Lunsumio) for relapsed or refractory follicular lymphoma (R/R FL), glofitamab (Columvi) for relapsed or refractory diffuse B cell lymphoma
resDetect™ Manufacturing Process Residue Detection Solutions
Product
Advertisement

Emphasizing Bio-Pharmaceutical CMC Residue Quality Control

resDetect™ is a series of reagent kits designed to follow international legal and regulatory requirements and guidelines for the detection of residual components in the biopharmaceutical manufacturing process.
Antibodies attacking viruses.
Product News

ProBioGen Partners With MAPP BIOPHARMACEUTICAL, INC. for Groundbreaking Development of Afucosylated Antibody Against Marburg Virus Disease

ProBioGen, is pleased to announce the execution of services and license agreements with MAPP BIOPHARMACEUTICAL, INC. to develop a cell line for an afucosylated antibody targeting Marburg virus (MARV) infection.
Safer Pharmaceuticals With Organ-on-Chip Models
Whitepaper

Organ-on-Chips Revolutionize Drug Safety Testing

This whitepaper explores the latest advancements in OOC platforms that can help to efficiently simulate drug toxicity responses.
An organoid.
Product News

Products and Services for Diversifying Preclinical Models

AMSBIO has expanded its range of products and services dedicated to assisting scientists diversify their preclinical models effectively to help bridge the gender discrepancy gap in many areas of research.
Advertisement